Ono Pharmaceutical

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents.

Launch date

1717

Employees

Market cap

Enterprise valuation

€4.9b (Public information from Sep 2024)

Osaka Osaka Prefecture (HQ)

https://www.ono.co.jp/

https://twitter.com/ono_pharma_pr https://www.linkedin.com/company/ono-pharmaceutical-co-ltd/

Revenues, earnings & profits over time

JPY	2021	2022	2023	2024	2025	2026	2027
Revenues	309.3b	361.4b	447.2b	502.7b	482.5b	512.8b	518.2b
% growth	6 %	17 %	24 %	12 %	(4 %)	6 %	1 %
EBITDA	116.8b	123.6b	161.9b	182.1b	122.6b	140.7b	140.3b
% EBITDA margin	38 %	34 %	36 %	36 %	25 %	27 %	27 %
Profit	75.4b	80.5b	112.7b	128.0b	76.2b	79.2b	80.2b
% profit margin	24 %	22 %	25 %	25 %	16 %	15 %	15 %
EV / revenue	4.5x	4.0x	2.8x	2.0x	2.3x	2.0x	1.9x
EV / EBITDA	11.8x	11.7x	7.7x	5.4x	8.9x	7.3x	7.0x
R&D budget	62.4b	75.9b	95.3b	112.2b	-	-	-
R&D % of revenue	20 %	21 %	21 %	22 %	-	-	-

Date	Investors	Amount	Round
Jun 1963	N/A	N/A	IPO
Jan 2000	N/A	N/A	IPO
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

Repare Therapeutics

Mediar Therapeutics